Ara
Treatment
The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
“Alcohol marketing to LGBTQ+ people”
Watch the video of the SHAAP/SARN 'Alcohol Occasionals' webinar, held over Zoom on 24 May 2023: "Alcohol marketing to LGBTQ+ people: Evolving strategies to target identity", by Dr David Whiteley .
Webinar on Addiction Prevention for Youth
The International Society of Substance Use Professionals (ISSUP) Indonesia and the Indonesia International Training and Treatment Centre (ITTC) together hosted the second webinar on "Addiction Prevention for Youth" on Sunday, May 21, 2023...
Indonesia's INEP Plus Online Training
ISSUP Indonesia organized the Introduction to Evidence-Based Prevention (INEP) Online Course as a national-level training in Indonesia with 17 participants. The training, conducted by Dr.dr. Kristiana Siste, SpKJ, and Dr. Elvina K...
Introduction to SAMHSA 4E’s Modern and Comprehensive Prevention System
SAMHSA recently introduced the 4 E’s as a “Modern and Comprehensive Prevention System” to support the work of prevention providers in States and communities.
The 4 E’s: Early Action, Easy Access, Equitable Opportunities and Effective...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
How alcohol consumption contributes to chronic pain
A team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and hypersensitivity.
Chronic alcohol consumption may make people more sensitive to pain through two different molecular mechanisms -- one driven by...
National Drug Observatories from Latin American and Caribbean countries meet in Lisbon for ‘COPOLAD week’
National Drug Observatories (NDOs) from Latin American and Caribbean (LAC) countries are gathering in Lisbon from 22–26 May for a week of activities under the COPOLAD III programme.
The overarching theme of the initiative will be...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
La FDA aprueba una nueva opción de tratamiento con buprenorfina para el trastorno por consumo de opioides
Para publicación inmediata: 24 de mayo del 2023
Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó la inyección subcutánea (para uso por debajo de la piel) de Brixadi...
Covering Substance Use and Addiction Responsibly
Stories about substance use and addiction can be among the thorniest that health and science reporters encounter. This topic carries a long history of marginalizing the people most directly affected. In addition, deeply ingrained societal misconceptions about substance use make it difficult to separate fact from fiction
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Assessment of Medical Cannabis and Health-Related Quality of Life
Abstract
Importance The use of cannabis as a medicine is becoming increasingly prevalent. Given the diverse range of conditions being treated with medical cannabis, as well as the vast array of products and dose forms available, clinical...
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people
Abstract
Background
SMART (Self-Management and Recovery Training) Recovery is a mutual-aid program informed by cognitive behaviour therapy and motivational interviewing that provides support for a range of addictive behaviours. SMART...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
Character Strengths and Recovery from Addiction
ISSUP Kenya present their Webinar on Insights from Positive Psychology and Psychology of Religion as applied to treatment and recovery from addiction.
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
National Drug Council equipping professionals with capacity to effectively treat substance use disorders in adolescents
Thirty adolescent treatment professionals in St. Kitts and Nevis are this week engaged in a training programme geared towards equipping them with the tools to identify, assess and treat adolescents with substance use disorders.
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Focal mu-opioid receptor activation promotes neuroinflammation and microglial activation in the mesocorticolimbic system: Alterations induced by inflammatory pain
Abstract
Microglia participates in the modulation of pain signaling. The activation of microglia is suggested to play an important role in affective disorders that are related to a dysfunction of the mesocorticolimbic system (MCLS) and are...